CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company
TriSalus Life Sciences, Inc.
Sign in to watch- Ticker
- TLSI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853009869
- Phone
- 415 336 8917
- Business address
- 6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
- Former names
- MedTech Acquisition Corp, MedTech Acquisition Corporation
Securities
- TLSI Common Stock Nasdaq
- TLSIW Warrant Nasdaq
- 4 Open-market sale Chief of Research sold 296 shares at $4.39 ($1,299)
- 4 Open-market sale Chief Commercial Officer sold 325 shares at $4.39 ($1,427)
- 4 Open-market sale Chief Regulatory Officer sold 316 shares at $4.39 ($1,387)
- 4 Shares withheld for taxes CEO and President gave up 2,693 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 14,650 shares (to pay taxes)
- 4 Grant or award CEO and President acquired 3,990 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Chief Commercial Officer acquired 561 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Commercial Officer sold 543 shares at $2.67 ($1,450)
- 4 Open-market buy Director bought 60,000 shares at $2.53 ($151,800)
- 4 Open-market buy Director bought 610,000 shares at $2.50 ($1,525,000)
- 4 Open-market buy CEO and President bought 39,682 shares at $2.59 ($102,776)
- 4 Open-market buy Chief Financial Officer bought 7,100 shares at $2.43 ($17,253)
- 4 Open-market buy Director bought 10,000 shares at $2.46 ($24,600)
- 4 Grant or award Director acquired 28,201 shares (grant or award)
- 4 Grant or award Director acquired 71,828 shares (grant or award)
- 4 Grant or award Director acquired 52,754 shares (grant or award)
Page 1 of 9 · 163 filings